Cargando…
Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?
Autores principales: | Parodi, Aurora, Gasparini, Giulia, Cozzani, Emanuele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271853/ https://www.ncbi.nlm.nih.gov/pubmed/32505779 http://dx.doi.org/10.1016/j.jaad.2020.06.003 |
Ejemplares similares
-
If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19
por: Xu, Qiannan, et al.
Publicado: (2021) -
The digital divide: How COVID-19's telemedicine expansion could exacerbate disparities
por: Bakhtiar, Mina, et al.
Publicado: (2020) -
COVID-19 and racial disparities
por: Shah, Monica, et al.
Publicado: (2020) -
Caution in the time of rashes and COVID-19
por: Vesely, Matthew D., et al.
Publicado: (2020) -
Algorithm for the classification of COVID-19 rashes
por: Ortega-Quijano, Daniel, et al.
Publicado: (2020)